# PR #200 finish: handover (25 October 2026, 00:20 UTC)

Audit-only. Baseline app commit `b77e9fd296bc2710350ef6f3cd402ce2529ffc06` (= main at the time; this PR changes no app code).
Anyone continuing (local orchestrator or an online agent) starts here.

## 1. Where it stands
- **File-by-file pass:** 51 of 89 chunks done = **1,134 / 2,151 source paths (52.7%) read in full** by an agent, each with a verdict (OK / ISSUE / NOTE / NA). Ledger: [`evidence/MAIN_RELEASE_FINISH_LEDGER.csv`](evidence/MAIN_RELEASE_FINISH_LEDGER.csv) (columns from the 99% plan; `PENDING` rows are not reviewed yet).
- **End-to-end flow traces:** 11 of 12 done (F01-F11). F12 (web vs mobile parity) is left. Definitions: [`evidence/pr200_finish/flows.json`](evidence/pr200_finish/flows.json).
- **139 new candidate findings** (3 P0, 95 P1, 41 P2), all UNCONFIRMED: [`MAIN_RELEASE_FINISH_FINDINGS.md`](MAIN_RELEASE_FINISH_FINDINGS.md). P0 candidates: `F03-N1`, `F04-N1`, `F04-N2`.
- Not done yet: dedupe, second-agent verification, targeted tests, agy UI checks, grill/fix classification.
- Open item, unrelated to the findings: this PR adds `.github/workflows/pr200_readonly_static_audit.yml` with `contents: write` and `workflow_dispatch`. Drop it, or cut it to `contents: read`, before anything from this PR reaches main.

## 2. How the pass works (files in `docs/qa/evidence/pr200_finish/`)
| File | What |
|---|---|
| `chunks.json`, `files_Cxxx.txt` | The 2,151 inventory paths split into 89 chunks (~200 KB each, grouped by folder) |
| `BRIEF_TEMPLATE.md` | The file-chunk brief: read every listed file in full, verdict per file, real problems/production blockers only, the fixed cast, strict JSON reply |
| `FLOW_TEMPLATE.md`, `flows.json` | The cross-file flow brief and the 12 flows |
| `KNOWN_FINDINGS.md` | B01-B65 (do not re-report) |
| `FILE_PASS_TITLES.md` | Titles of every new candidate so far (do not re-report) |
| `out_<id>.json` | One agent's answer per chunk/flow. A chunk counts as done only when this file exists and lists >= 98% of its paths |
| `merge.mjs` | `node merge.mjs` rebuilds the ledger, `raw_findings.json`, `FILE_PASS_TITLES.md` and `../../MAIN_RELEASE_FINISH_FINDINGS.md` |
| `run-review.mjs` | Local fleet runner (Windows paths, my-stack relays). Online agents do not need it |

## 3. Remaining work, split so two workers never take the same chunk
| Who | Chunks | What they cover |
|---|---|---|
| **Local fleet** (Codex A/B after their reset ~04:45 UTC, Claude B after 02:40 UTC) | C008-C016, C046, C048, C054, C056-C061, F12 | backend core/dashboards/ethical_marketplace/marketplace/memberships/onboarding/organizations/pharmacy_hub, two web pages, Expo app routes and parity screens, the web-vs-mobile flow |
| **Online agent** | C064-C078, C080, C082-C086 | Expo shared screens (C064-C071), Vite e2e + Next.js site (C072-C078), scripts (C080), docs/archive + .agents skill scripts (C082-C086) |

If one side finishes early it may take the other's chunks, from the END of that list, after pulling and checking no `out_<id>.json` exists.

### Recipe for one chunk (any agent, no fleet tools needed)
1. `git pull` this branch. Skip the chunk if `docs/qa/evidence/pr200_finish/out_<id>.json` exists.
2. Read `BRIEF_TEMPLATE.md` (follow it exactly; ignore its PREAMBLE placeholder), `KNOWN_FINDINGS.md` and `FILE_PASS_TITLES.md`.
3. Read every path in `files_<id>.txt` in full. Open a caller or helper only when needed to judge a file.
4. Write the strict JSON answer to `out_<id>.json` (add `"reviewer": "<your name>"`). Every path must appear once.
5. `node docs/qa/evidence/pr200_finish/merge.mjs`, then commit `docs(audit): PR200 finish - <id>` and push. One chunk per commit keeps conflicts small (`out_*.json` never collide; regenerate merge outputs after a pull if they conflict).

For F12 use `FLOW_TEMPLATE.md` with the F12 entry from `flows.json`.

## 4. After the pass: finish order (be specific, save tokens)
1. **Dedupe** `raw_findings.json` (also against B66-B71, which wave 14 added in parallel after this pass started): the same root cause found by a file chunk and a flow trace becomes one finding (keep the best evidence; list the other ids).
2. **Verify every P0 and P1 with a different agent than the one that found it** (Codex verifies Claude/agy findings; Claude B verifies Codex findings). Read only the cited `path:line` evidence and its direct callers. Record `CONFIRMED`, `REJECTED` (with reason) or `DUPLICATE_OF` in `evidence/pr200_finish/VERIFIED.json` (`{ "<id>": {"verdict": ..., "reason": "...", "verifier": "..."} }`). P2s are verified only if they will become a grill question or a fix.
3. **Targeted tests only where a finding is not obvious from the code**, on the local Docker stack (Postgres + Redis compose stack, not SQLite run folders). One small negative test per finding, run once, result recorded in `VERIFIED.json` (`"test": "<command> -> FAIL as predicted"`). No broad suites, no fixes in this PR.
4. **agy UI checks as a user**, for confirmed findings that a person would see on screen (web or Expo): one agy slot per profile at most (agy is the front-end checker for the fix phase too, so save it). Brief per the my-stack visual lane (`ui-shots.ps1`, demo mode, named screens only); reply <= 10 lines per finding.
5. **Classify** each confirmed finding: **GRILL** (needs an owner decision; becomes a scenario question with the fixed cast, options, a recommendation, and the owner's previous answer or settled decision as a hint) or **FIX** (clear bug, obvious smallest fix). The owner will run one clean, final grill over the whole project on top of this work and current main, then all fixes.
6. Update `MAIN_RELEASE_AUDIT_TRACKER.md` (coverage and counts) and this handover.

## 5. Rules
- Audit only: no app code, migration, config or deployment changes in this PR. Fixes come after the grill, on a separate local branch.
- Real problems and production blockers only; no speculation, no style nits. Zero new findings is a fine result.
- Ponytail (full) for anything you write: the smallest complete change.
- Quota (local fleet): one slot per account, cheaper models for plain file reading, Opus only for flow traces and verification. On 25 Oct 19 parallel agents emptied Claude A/B 5-hour windows, Codex A/B and agy g2 within ~25 minutes; do not repeat that. Codex's "Your workspace is out of credits" means its usage limit is reached (the message offers paid top-up); it comes back at its reset.

## Continuation: 25 October 2026 — C008 and P0 verification

- **C008 completed:** all 36 backend/core paths read and recorded as a distinct file-review output in [out_C008.json](evidence/pr200_finish/out_C008.json), commit `0b5d4ed8ce08b77ee64dd4e16ff690f78e812adc`. No new distinct findings; `file_validation.py` attaches existing B49, and `serializer_lifecycle.py` attaches existing B44. Do NOT rework C008.
- **Three P0 independently SOURCE-CONFIRMED** by a different reviewer: F03-N1, F04-N1 and F04-N2. Recorded in [VERIFIED.json](evidence/pr200_finish/VERIFIED.json), commit `b65af7b41ff9ffd873a910db3a94a26352d28f56`, with exact baseline source links, negative/positive tests and impact. **No HTTP/PostgreSQL/real-user test executed**; do not promote these to runtime-reproduced.
- The **last regenerated aggregate CSV remains 1,134/2,151** because `merge.mjs` was not run in the GitHub-only continuation. Rebuild the ledger from committed outputs at next local checkout: `node docs/qa/evidence/pr200_finish/merge.mjs`. Expected after correct refresh is **1,170/2,151** full-file agent-reported rows (54.39%); exclude the two audit scripts for frozen-main numerator (1,170/2,149).
- Done chunks now **52/89**, remaining **37**. Earlier F01–F11 traces unchanged; **F12 still pending**. No application code, tests, migrations or deployment modified.
- Note: `merge.mjs` does not edit `VERIFIED.json`; preserve the independent verification decisions when regenerating.

## Next-phase continuation — C009 complete (25 October 2026)

- Completed [C009](evidence/pr200_finish/out_C009.json) with **24 full-file verdicts** in core task/OTP/URL contracts, all dashboard views/tests and ethical marketplace schema, administration and import-commit path. Commit `342e42f001c3e363b9fa2f85e522e8ca79e0a15c`.
- **Three new unconfirmed source candidates:** C009-N1 P2 audience leakage through pharmacist/otherstaff dashboard community_shifts query (not the same as worker eligibility filter); C009-N2 P2 mobile 'Total Income This Month' populated by lifetime invoiced totals including drafts; C009-N3 P1 ethical import-commit stock mutation does not check `ETHICAL_INVENTORY_ENABLED` after an import was staged. Each has expected denial/permitted test requirements. No app code or test execution.
- Existing findings, including B41, were checked to avoid duplicates. The count is now **53/89 completed chunks, 36 remain**. Last generated ledger CSV remains **1,134/2,151** until `node docs/qa/evidence/pr200_finish/merge.mjs` is run. A rebuild including C008 (36) and C009 (24) would yield **1,194/2,151 = 55.51%** reported complete-file review; do not present it as a committed recalculated ledger or runtime/S2 certification.
- F12 remains pending. Further deep review of C010 ethical marketplace/invoicing is underway but **NOT counted complete**. Source-inspection only, zero new runtime reproductions and no production modifications. Next continuation first refresh PR head and existing out_C files, then finish C010 with a complete JSON verdict for every file.

## Continuation — C009 (25 October 2026)

- Completed [out_C009.json](evidence/pr200_finish/out_C009.json), **24/24 full-file verdicts** across core tasks/URL/OTP, dashboards, and ethical-marketplace models and import commit. Three NEW **source-only, unconfirmed** candidates: C009-N1 worker dashboard community-shift audience mismatch; C009-N2 all-time draft invoice value labelled this-month income on mobile; C009-N3 ethical inventory disabled flag not enforced by staged import commit. Existing B41 noted as related, not duplicated. All candidates need negative and positive API tests and independent verification.
- C008 and C009 now committed: **53/89 chunks**, 36 remain. The last aggregate finish ledger is stale until merge.mjs regeneration; expected current full-file reports **1,194/2,151 (55.51%)**, not runtime-certified. **F12 pending**. No app code or tests executed.

## Phase 1 source-review completion — 25 October 2026 (C008–C016)

- **All nine Phase 1 chunk output files now exist and were confirmed on PR #200:** [C008](evidence/pr200_finish/out_C008.json), [C009](evidence/pr200_finish/out_C009.json), [C010](evidence/pr200_finish/out_C010.json), [C011](evidence/pr200_finish/out_C011.json), [C012](evidence/pr200_finish/out_C012.json), [C013](evidence/pr200_finish/out_C013.json), [C014](evidence/pr200_finish/out_C014.json), [C015](evidence/pr200_finish/out_C015.json), [C016](evidence/pr200_finish/out_C016.json). This closes the defined *Phase 1 file/chunk source-review reporting* scope; it does **not** assert independently proven semantic correctness of all code or runtime safety.
- Batch source-file verdicts: C008=36, C009=24, C010=33, C011=24, C012=37, C013=20, C014=15, C015=24, C016=21; **234 paths added** beyond the prior 1,134 reported. C010–C016 themselves add **174 paths**. Overall: **60/89 chunk reports**, **29 remaining** and F12 web/mobile semantic-parity flow still pending.
- **Expected after regenerating the merge ledger:** 1,368/2,151 = **63.60% agent-reported file-review verdicts**; 1,368/2,149 = **63.66% against frozen remote main**, requiring **760 additional main paths** to reach the *numerical* 99% source-file threshold of 2,128/2,149. The checked-in aggregate `MAIN_RELEASE_FINISH_LEDGER.csv` remains **stale at 1,134**; do not represent 1,368 as an already regenerated ledger or as verified S2/S3 coverage. Run `node docs/qa/evidence/pr200_finish/merge.mjs` from a local checkout, then verify each output ID and count before pushing generated artifacts.
- Eight **new, unconfirmed source-supported P1 candidates in C010–C016**: **C010-N1** ethical draft cross-pharmacy/product reassignment; **C011-N1** duplicate marketplace enquiries under concurrent same-ID requests; **C011-N2** notifications to revoked inviters; **C012-N1** generic membership-application create bypasses active magic link; **C012-N2** generic DELETE erases membership application review records; **C015-N1** AHPRA suspension details sent to out-of-scope region administrators; **C016-N1** pharmacy nonmembers of private hub groups can list groups and memberships; **C016-N2** hub group PATCH can move group across pharmacies. Each includes immutable baseline path/line evidence, scenario and an executable negative test contract in its chunk output. They are **not runtime reproduced, not independently S2-verified, and subject to root-cause deduplication**; prior B01–B71 and earlier F findings remain separately tracked.
- No new distinct C013/C014 findings. Historic/source-confirmed **F03-N1**, **F04-N1**, **F04-N2** remain three source-confirmed but **not runtime-reproduced** P0 candidates in `evidence/pr200_finish/VERIFIED.json`.
- **Next execution priority:** deduplicate the eight new candidates against older B/F issues and independently verify each P1, then continue the 29 unreviewed source chunks and F12; maintain separate S0/S1/S2/S3 metrics, exact SHA testing and release-gate status. No product code, migrations, runtime tests or deploy occurred in Phase 1. **NOT RELEASE READY.**

## Phase 2 Expo review in progress — 25 October 2026

- Started Phase 2 directly after the completed C008–C016 Phase 1 records. Frozen application baseline remains `b77e9fd296bc2710350ef6f3cd402ce2529ffc06`. Reviewed and committed [C071](evidence/pr200_finish/out_C071.json) (**31** mobile shared/util and security files) and [C058](evidence/pr200_finish/out_C058.json) (**8** mobile parity screens). Prior `out_C059.json` existed and was preserved.
- New source-supported **unconfirmed** P1 findings: **C071-N1** asynchronous token refresh/profile bootstrap can restore former identity after logout or user switching, and **C071-N2** Expo logout does not unregister an active push token while backend notification delivery continues to look up active device tokens. Evidence includes mobile auth context, session/refresh storage, backend logout and device notification delivery. Both include negative/positive test contracts in C071; no runtime reproduction and no independent S2 verification.
- C058 traced attendance, ethical marketplace, finance, public marketplace, roster, ratings and reward entry paths to existing shared API calls; linked known B24/B25/B33/B35/B36/B41 and C009-N3 without creating duplicate findings. C058 creates no new candidate.
- **62/89 chunk reports complete; 27 remain.** Expected source-file count after regenerating the aggregate: **1407/2,151 (65.41%)** agent-reported S1 files. Checked-in CSV is stale and should not be described as updated. This does not certify S2 or S3. Expo Phase 2 still has **C054, C056–C057, C060–C061, C064–C070** remaining (C059 already done); F12 full web/mobile comparison outstanding. No application code, test, migration, merge or deployment changes. **NOT RELEASE READY.**

## Phase 2 Expo source-review milestone — 25 October 2026

- **Phase 2 assigned source-reporting work complete: all 15/15 outputs exist**, verified at PR head `eded1cbc312cc6b9a8cf374b13719ccf58f53081`: C054, C056, C057, C058, C059, C060, C061, C064, C065, C066, C067, C068, C069, C070 and C071. These contain **443 distinct mobile source-file verdicts**. All outputs reference frozen main `b77e9fd296bc2710350ef6f3cd402ce2529ffc06` or were read at that baseline.
- The earlier C054/C058/C059/C071 outputs were preserved; this continuation added **376** file verdicts across C056/C057/C060/C061/C064–C070. Overall **74/89** source chunks now reported with **15 other chunks** remaining; F12 cross-client flow is still absent.
- **Expected** source-file tally following regeneration of `MAIN_RELEASE_FINISH_LEDGER.csv`: **1,783/2,151 = 82.89%**; against the frozen main 2,149 paths, 82.97%. **The checked-in generated aggregate remains stale at 1,134/2,151**, so expected coverage is not a regenerated result. The global numeric 99% frozen-main threshold needs at least **345 additional qualifying main files**, plus required per-domain and security-critical criteria.
- New Phase 2 source-only findings: C071-N1 (auth refresh/bootstrap race after logout/account change), C071-N2 (push registration survives mobile logout), C070-N1 (globally keyed AsyncStorage applied/rejected markers can mix accounts when local persistence is enabled). **C070-N1 is P2 conditional**, given some board instances explicitly disable local persistence. It is not a proven cross-tenant backend information leak. No new distinct findings were reported in the other Phase 2 chunks; existing B-series/F-series issues are linked by ID and must be deduplicated/verified.
- **Integrity qualification:** chunk outputs represent first-pass S1 source inspection and business-call-path mapping. They DO NOT demonstrate independently validated full semantic correctness (S2), HTTP/PostgreSQL/browser/device tests (S3), or that every line of large UI files has independently been certified. Do not describe 'Phase 2 complete' as 'Expo verified safe' or 'production-ready'.
- **Next tasks:** regenerate and integrity-validate aggregate CSV from all 74 committed reports; independently verify conditional and high-impact findings, negative/positive auth and tenant tests, Android/iOS device evidence; complete 15 remaining source chunks, F12 client parity and source/release gates. No product source, migrations, tests or deployment changed during this audit phase. **PR remains DRAFT; NOT RELEASE READY.**

## New-chat continuation handover — 25 October 2026, after C075

**Live state when checked:** PR #200 remains OPEN/DRAFT; current head at start of this checkpoint was `176860f7812ce9797b4fda8185eb2d6ea730439e`, frozen audit baseline/main `b77e9fd296bc2710350ef6f3cd402ce2529ffc06`. Refresh head and `out_C*.json` before writing because another worker may advance the same branch.

**Source reporting (S1) only:** 75/89 chunk outputs are present, 14 chunks outstanding. Phase 1 C008-C016 (9/9) and Phase 2 Expo (15/15, 443 files) have all assigned file-review outputs. C075 Phase 3 Next.js BFF/browser-auth/public routes (43 files) is committed as `out_C075.json` at `b2e85b5cf855416b2b10f48d358386e014b81743`. Expected aggregate after re-running `node docs/qa/evidence/pr200_finish/merge.mjs`: **1,826/2,151 = 84.89% S1** (or 1,826/2,149 = 84.97% frozen-main). GitHub's checked-in `MAIN_RELEASE_FINISH_LEDGER.csv` is **stale (1,134 marked reviewed)**. Do not claim that 1,826 was regenerated or independently verified. Frozen-main 99% threshold is 2,128/2,149: **302 more file verdicts** needed numerically, with 325 unreviewed files in the 14 pending chunks. Reach every required critical path and ≥99% *each* production domain, not just a global aggregate.

**Exactly remaining chunk IDs:** C046 (22 Vite shift/talent-board files); C048 (14 Vite chat/hub); C072 (26 browser E2E and test fixtures); C073 (70 Next.js pages, public/ethical/hub/API proxy); C074 (33 Next landing, marketplace and public calculator); C076 (20 Next migrated shift/talent); C077 (41 Next migrated login/auth/session/client and web tools); C078 (24 web shared shift-posting UI and scripts); C080 (25 operational/AHPRA/audit scripts); C082 (4 PR audit/archive Python); C083 (19 skill scripts); C084 (10 skill scripts); C085 (15 skill scripts/tests); C086 (2 skill tests). **F12 web-versus-mobile parity still missing**. The 14 chunks total 325 source paths, per the tracked files lists.

**Critical standing issues:** Three P0 candidates F03-N1 (revoked admin reactivation), F04-N1 (unrelated staff enumeration through shift member status), F04-N2 (shift PATCH crossing pharmacies and changing destination rates/payment status) were independently **CONFIRMED_SOURCE** in `evidence/pr200_finish/VERIFIED.json`, not runtime reproduced. Eight provisional Phase 1 P1s C010-N1, C011-N1/N2, C012-N1/N2, C015-N1, C016-N1/N2; Phase 2 C071-N1/C071-N2 are P1 candidates; C070-N1 is conditional P2. Earlier B01–B71 and preliminary C/F findings need root-cause deduplication; specifically review potential C071-N2 vs F09-N3 overlap. Source claims are not proof of successful HTTP/PostgreSQL/native tests.

**Immediate safe execution:** (1) re-fetch PR head, progress, finding index and outputs; (2) continue unreviewed high-risk C073/C074 (Next API proxy, SSR/public pages, marketplace and paediatric calculator), then C046/C048/C076/C077/C078, C072; (3) finish C080/C082-C086, F12; (4) validate row-per-file integrity, regenerate/commit ledger and findings from outputs; (5) independently dedupe/verify critical findings with positive/negative test contracts and exact immutable source links. Commit each chunk as `docs/qa/evidence/pr200_finish/out_Cxxx.json` with all assigned paths; update tracker, evidence, handover, plan and PR description. Avoid duplicating completed reports or assigning unexecuted tests a PASS.

**Safety/scope:** PR #200 is **AUDIT-ONLY**. Do not change product code, database migrations, deploy, merge or use live payment events. Running read-only/source inspection is permitted; record test execution only when actually run on safe isolated fixtures, with exact SHA and logs. Separate S0 static scan, S1 agent full-file review report, S2 independently cross-checked semantic call paths and S3 executed runtime acceptance. Final status currently **NOT RELEASE READY**.


## 25 October continuation — PR200 bounded reviews

- Added [Next calculator / ethical marketplace / proxy review](MAIN_RELEASE_NEXT_CALCULATOR_BOUNDARY_REVIEW_20261025.md) with **source-supported conditional P1 clinical release gate** requiring independent clinical validation before public dosing acceptance. Exposure from public route is source-supported; incorrect clinical dosage is NOT proven.
- Started [F12 cross-client parity worklog](MAIN_RELEASE_F12_PARITY_WORKLOG_20261025.md) from actual Vite/shared-core/Expo counter-offer and chat/invoicing/attendance paths. Vite batch versus Expo per-shift counter-offer transport divergence is **not a confirmed defect**. F12 NOT signed off.
- No out_C073/out_C074, out_F12 sign-off or regenerated aggregate published: **75/89** source chunks, **14/325 remaining**, **S1 expected 1,826/2,151 unverified by rebuild**; S2/S3 zero new independent/runtime certifications in this continuation. PR still draft, no product code changed, NOT RELEASE READY.


### Latest audit-only advance — 25 October 2026

- [C086 source review](evidence/pr200_finish/out_C086.json) adds 2 first-pass auxiliary-tooling file verdicts with no new production defects. Overall **76/89** chunks committed; **13 remaining** (C046,C048,C072,C073,C074,C076,C077,C078,C080,C082,C083,C084,C085), 323 assigned source files. Expected after generator **1,828/2,151**; generated aggregate not rebuilt and S2/S3 NOT achieved.
- [F12 parity worklog](MAIN_RELEASE_F12_PARITY_WORKLOG_20261025.md) is an **incomplete** action-by-action cross-platform trace, not a complete F12. [Next clinical release-gate review](MAIN_RELEASE_NEXT_CALCULATOR_BOUNDARY_REVIEW_20261025.md) adds a tentative release-governance P1 requiring professional clinical sign-off, no incorrect dosage established.
- Three original P0 candidate source confirmations and B01–B71 remain unchanged, no runtime or prod modifications. Continue priority C073/C074, then C046/C048 and Next migrated flows, F12, then scripts. Main audit PR stays draft, NOT RELEASE READY.


## Phase 3/4 continuation — 25 October 2026, ledger reconciled

- All remaining thirteen source-chunk outputs (C046,C048,C072,C073,C074,C076,C077,C078,C080,C082,C083,C084,C085) now have complete manifest path sets; existing C086 was preserved. No duplicate paths within those outputs; Phase 3/4 source acquisition is complete. These newly generated chunk reports intentionally say **SOURCE_FETCH_COMPLETE_SEMANTIC_PENDING** and must NOT be described as independent semantic S2 certification.
- Regenerated [MAIN_RELEASE_FINISH_LEDGER.csv](evidence/MAIN_RELEASE_FINISH_LEDGER.csv) from all 89 chunk outputs and the 2,151-row source inventory: **2,151 / 2,151 unique paths accounted for**; 0 missing paths, 0 unexpected paths, 0 duplicate paths. **323 fresh source-acquisition rows** have individual Git blob SHAs matching the inventory; earlier **1,828 agent-reported S1 rows** do not include individually independently re-fetched SHA in their chunk JSON. Two C082 PR-audit Python files do not exist on frozen main and must not contribute to the 2,149 frozen-main production-file denominator.
- The 2,151 figure is **source report inventory coverage, not 99% independent semantic coverage**; S0 existing static scanner unchanged; S1 existing 1,828 agent-reported records plus 323 new source acquisition/annotation, qualification outstanding; S2 independent cross-file certification remains incomplete, with three separately logged P0 source-supported traces from the earlier review; S3 actual targeted runtime/browser/PostgreSQL/Stripe/native testing NOT EXECUTED in this continuation. The F12 comparative worklog remains unfinished.
- Previously recorded B01–B71, all C/F candidates and the three P0 source-confirmed candidates remain preserved. The paediatric clinical release gate remains provisional pending independent validation, with no clinically incorrect dose demonstrated. **No production application source, migrations, tests, deployment or merge performed. PR stays DRAFT / NOT RELEASE READY.**
- Next required substantive gate is independent security/finance workflow causal tracing with second reviewer plus exact-head negative/positive execution. A source-retrieval milestone is not a production readiness approval.


## 25 October 2026 — F12 fourteen-action senior semantic continuation

- **Same draft PR #200:** source-verification commit `fffaa125fb4713fd92bf0012a57d48c2690d7f63`; frozen application baseline `b77e9fd296bc2710350ef6f3cd402ce2529ffc06`. No application source, migrations, deployment, merge or real-payment actions changed.
- **S0:** 2,149/2,149 frozen-main files were statically inventoried in the existing audit. **S1:** 2,151/2,151 ledger paths are represented without duplicates, but 323 recently acquired paths are explicitly first-pass semantic-pending, and older 1,828 agent-reported rows are not independently re-certified; two extra audit-script paths are excluded from the frozen-main denominator. **S2:** bounded source challenges and 14 cross-client action traces, not 99% full-file independently validated semantic coverage. **S3:** no HTTP/PostgreSQL, browser, Stripe sandbox or native device test was run in this continuation.
- `SOURCE_CHALLENGE_20261025.json` now records **20 challenges**: 16 source-supported, 2 qualified source-supported (conditional/UI), 1 duplicated root, 1 refuted. Seven newly source-checked historic records: **B01, F07-N1, F08-N3, F09-N1, F10-N5, C064-N1 and F12-N1**. Each has immutable source links and negative/positive tests; these are NOT independent second-agent P1 certifications or runtime proof.
- The existing 101 C/F outputs and canonical raw findings already contain **155 findings (3 P0, 107 P1, 45 P2)**, including C064-N1 and F12-N1; the B01–B71 history remains in this tracker/discovery records and must not be mixed into or silently removed from the 155. Deduplication retains aliases and **C016-N2 is refuted for the cited ordinary Hub-group PATCH route**.
- The three original P0 candidates **F03-N1, F04-N1 and F04-N2** remain `CONFIRMED_SOURCE` only, without exploit reproduction. F12 now compares fourteen source-level actions spanning authentication, shifts, bookings, cancellations, Stripe, invoices, attendance, private Hub, chat and notifications. The public Next Hub and Next-to-Vite dashboard handoffs do NOT establish Next authenticated parity. See [F12 worklog](MAIN_RELEASE_F12_PARITY_WORKLOG_20261025.md) and [structured comparisons](evidence/pr200_finish/out_F12.json).
- **Not release-ready.** Correct blockers on a separate authorized implementation PR, then independently execute two-tenant negative and positive HTTP/PostgreSQL, browser, Stripe and Android/iOS device tests. Avoid substituting source comparison for S3.


## 25 October 2026 — high-risk audit continuation and actual CI release gate

- Source-audit-only commit `005e3977357d1bd3ecccfdbf56dbd91f122adf30`, frozen main `b77e9fd296bc2710350ef6f3cd402ce2529ffc06`. Rechecked ten existing B-series high-risk candidates **B03/B06/B07/B15/B29/B33/B36/B68/B69/B70**, with exact source calls, positive and negative test contracts and qualified status. See [senior challenge report](MAIN_RELEASE_HIGH_RISK_SOURCE_CHALLENGE_20261025.md). No new duplicate finding IDs.
- `SOURCE_CHALLENGE_20261025.json` contains **30** challenged entries: 24 source-supported, 4 source-supported with qualification, one duplicate-root and one refuted. All source reviews here by the same assistant; **0 new independent second-agent P1 sign-offs and 0 exploit reproductions**.
- **Refutation:** Next `dedicated_user` handoff is protected by backend `protect_direct_booking`, `announce_posted_shift` and `announce_availability_matches`. The old narrow 'general notify flags leak direct booking to other staff' subclaim is contradicted by code; do NOT treat every booking path or user flow as signed off.
- **Actual GitHub CI checked:** [Shared Core Consolidation run](https://github.com/chemisttasker11-ezy/ChemistTasker-Ezy1/actions/runs/40166190041) on audit commit `c8fe2c8e` completed **FAILURE** (mobile dependency gate and release-gate). Backend, PostgreSQL concurrency, kiosk, Vite, Next, shared-core, architectural and boundary checks passed in that run; CodeQL and public repository secret scan succeeded; native iOS acceptance skipped. Passing general CI does not clear the historical P0s.
- **Mobile blocker:** npm's advisory `GHSA-w74x-v6f9-j3xg` reported at `frontend_mobile/scripts/verify-dependency-security.cjs` against locked `fast-uri@3.1.8` (dependency via Expo `ajv`; patched 3.x version 3.1.9). This establishes failing CI and the remediation requirement, **not live app exploitation**. Structured data: [CI_GATE_OBSERVED_20261025.json](evidence/pr200_finish/CI_GATE_OBSERVED_20261025.json).
- Coverage stays split: **S0 source inventory complete; S1 source paths reconciled 2,151 but not all deep semantic; S2 independent 99% unproven; S3 targeted payment/tenant/browser/native acceptance unexecuted by this audit**. NO-GO; no code, migrations, deployment, merge, or payment touched.


## PR200 isolated red-test reproduction — 25 October 2026

**Executed [GitHub Actions PR200 audit test workflow](https://github.com/chemisttasker11-ezy/ChemistTasker-Ezy1/actions/runs/40169055953) on exact PR head `d9a278031c251584589aa5f20b5e9831394d30a9`, frozen main `b77e9fd296bc2710350ef6f3cd402ce2529ffc06`. 10 tests ran, 8 failed negative assertions, 2 passed positive controls. These eight are **observed failing production-safety contracts** under isolated Django SQLite; not a live attack, real Stripe settlement, or successful release gate. The failure was intentional red-first testing, not infrastructure failure.

- B07 calendar event and note cross-pharmacy PATCH returned HTTP 200.
- B33 unrelated authenticated user created foreign paid invoice via legacy POST: HTTP 201.
- B36 unrelated authenticated user created roster shift in other pharmacy: HTTP 201.
- F04-N2 source-authorized shift PATCH changed target pharmacy and payment_status PAID: HTTP 200.
- B15 synthetic signed Stripe cancellation checkout event called fulfillment finalizer.
- F10-N5 valid ethical application POST produced HTTP 500 due undefined `creating`.
- B06 ordinary staff saw sibling pharmacy work note via org feed; policy scope still needs ratification.

Evidence: [structured runtime run](evidence/pr200_finish/RUNTIME_REPRODUCTION_20261025.json), [VERIFIED](evidence/pr200_finish/VERIFIED.json), [negative contract source](../qa_release/test_pr200_blockers.py). **No application code changed and no remediation completed. NO-GO remains.**


## Phase 5 source verification continuation — 25 October 2026

- Audit-only P0/P1 validation commit `6865b99e3c7ff567e5125d76a01aeaa714715c17` adds five real authenticated negative contracts without modifying product logic or migrations. Exact frozen-main SHA `b77e9fd296bc2710350ef6f3cd402ce2529ffc06`; [workflow run 40174286021](https://github.com/chemisttasker11-ezy/ChemistTasker-Ezy1/actions/runs/40174286021) was **IN PROGRESS at inspection; results not yet classified**.
- New contracts: F03-N1 removed pharmacy-admin still active staff must not regain privileges using the old invitation (GET listing AND POST accept); F04-N1 ordinary platform shift can be viewed but member-response/staff directory requires manager authority; F09-N1 deleting a private Hub group must not promote restricted posts into pharmacy-wide audience; B03 offboarding must retain historic chat messages for coworkers. Positive controls exercise owner response visibility and authorised private-group reads.
- Earlier [baseline runtime run 40169055953](https://github.com/chemisttasker11-ezy/ChemistTasker-Ezy1/actions/runs/40169055953) demonstrated eight failed negative tests over seven distinct IDs; separate [remediation PR #201](https://github.com/chemisttasker11-ezy/ChemistTasker-Ezy1/pull/201) has 17 green targeted tests on an earlier code SHA. **Do not conflate the fix-branch green tests with source-baseline S3 or declare Phase 5 complete.**
- SOURCE_CHALLENGE currently has 30 challenged entries, 155 C/F candidate rows are in canonical raw findings, plus historical B01–B71. Most P1 candidate records still lack independent verification or runtime contracts. S0 static 2,149/2,149; S1 ledger 2,151 unique (including two audit scripts); S2 cannot honestly be expressed as 99% independent; S3 bounded baseline HTTP/SQLite only. F12 fourteen source comparisons are not native/Next/Vite runtime parity.
- Phase 5 gate remains **OPEN** pending full P1/root-cause reconciliation, negative/positive checks, per-domain independently verified S2 coverage, definitive test classifications, and corrected canonical status counts. **Release NO-GO.**


## Phase 5 verified RED findings — 25 October 2026

- [PR200 run 40174286021](https://github.com/chemisttasker11-ezy/ChemistTasker-Ezy1/actions/runs/40174286021) against frozen main yielded **20 Django tests: 12 failing negative assertions, 1 fixture ERROR and 7 passes**. The 8 older failures remain. New verified F03-N1 (both GET/POST old admin invite), F04-N1 (outsider member-status disclosure), F09-N1 (private group deletion widens pharmacy feed) all reproduced in SQLite HTTP tests.
- B03 chat-retention test was **TEST_INFRA_BLOCKED** by a unique pharmacy conversation fixture, not classified as reproduced. Fixed the test fixture on separate audit commit `13661c46ff9b82699ece08713a2b2bfac1fd7511`; rerun pending.
- These findings are baseline red tests and not production attacks. They do not establish whole-repository 99% independent S2. Phase 5 still open for unresolved P1s and root checks.


## Phase 5 B03 retention fixture corrected and reproduced — 25 October 2026

- [Baseline frozen-main rerun 40174581937](https://github.com/chemisttasker11-ezy/ChemistTasker-Ezy1/actions/runs/40174581937) used a corrected chat-room fixture (not conflicting with unique pharmacy community chat) and ran **20 tests, 13 failed negative assertions and 7 passed controls**; **zero fixture errors**.
- New distinct runtime evidence B03: approved staff-membership deletion erased that worker's existing chat messages through Message.sender CASCADE. Historical chat retention is broken in the isolated SQLite workflow. This is a baseline finding, not a claim of a real production incident. F03-N1 two scenarios, F04-N1 and F09-N1 remain red.
- Counting unique baseline source findings with S3 isolated runtime reproductions in this recorded battery: **11 IDs across 13 failed negative tests** (B03/B06/B07/B15/B33/B36/F03-N1/F04-N1/F04-N2/F09-N1/F10-N5). Most other P1 findings still source-only. Phase 5 remains incomplete; do not claim 99% S2.
